Clinical Trial Update: Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety of Diamyd in adults with latent autoimmune diabetes in adults (LADA) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Autoimmune Diabetes in Adults

Drugs mentioned

• Diamyd

Snippet

Sponsor: Diamyd Therapeutics AB | Conditions: Latent Autoimmune Diabetes in Adult (LADA) | Phase 2 | Status: COMPLETED